The round up class action lawsuit is one of the largest mass tort cases in American history. Bayer has already committed over $10.9 billion to settle tens of thousands of cancer claims linked to its Roundup weed killer.
If you used Roundup and later developed cancer, you may still be able to file a claim in 2026. New cases are still being accepted, and individual payouts have ranged from $5,000 to over $2 billion depending on the severity of the case.
This guide covers every detail you need for 2026. You’ll find updated settlement amounts, eligibility rules, filing steps, deadlines, tax questions, and funding options.
Over 100,000 lawsuits have been filed against Monsanto and Bayer since the first landmark verdict in 2018. That number keeps growing.
Round Up Class Action Lawsuit
The round up class action lawsuit refers to the massive wave of legal claims filed against Monsanto and its parent company Bayer. These lawsuits allege that Roundup’s active ingredient, glyphosate, causes cancer, particularly non-Hodgkin lymphoma.
Technically, most Roundup cases are part of a multidistrict litigation (MDL), not a traditional class action. The difference matters. In a class action, one lawsuit covers everyone. In the MDL, each person’s case is handled individually but grouped together for efficiency.
The litigation is consolidated under MDL 2741 in the U.S. District Court for the Northern District of California. Judge Vince Chhabria has overseen the proceedings since they began.
The first major verdict came in August 2018 when a jury awarded school groundskeeper Dewayne Johnson $289 million (later reduced to $78.5 million). That case cracked the door open for thousands more.
| Detail | Info |
|---|---|
| Litigation Type | Multidistrict Litigation (MDL 2741) |
| Court | U.S. District Court, Northern District of California |
| Defendant | Bayer AG / Monsanto |
| Active Ingredient at Issue | Glyphosate |
| Total Claims Filed | Over 100,000 |
| Primary Cancer Linked | Non-Hodgkin Lymphoma |
Since that first verdict, three bellwether trials have resulted in plaintiff victories. Each sent a clear message: juries believe Roundup can cause cancer.
Roundup Lawsuit Update 2026
The Roundup litigation remains active heading into 2026, with thousands of claims still pending resolution. Bayer continues to settle cases while simultaneously appealing certain court rulings.
In 2020, Bayer announced a $10.9 billion settlement to resolve roughly 75% of the pending cases at that time. But new claims have piled up since then, and the company has set aside additional reserves.
By late 2025, Bayer had resolved approximately 100,000 claims. However, an estimated 30,000 to 40,000 additional cases remain active or newly filed.
Bayer has also pursued a legal strategy to limit future liability. The company sought U.S. Supreme Court review of the Hardeman verdict, arguing that federal EPA registration of glyphosate should preempt state-level failure-to-warn claims. The Supreme Court agreed to hear the case in 2024, and a decision in 2025 could reshape the entire litigation going into 2026.
- Bayer set aside an additional $4.5 billion in 2024 for future Roundup-related liabilities
- New filings continue in state and federal courts
- The Supreme Court ruling on federal preemption will be the most significant development for 2026 cases
- Settlement negotiations for remaining claims are ongoing
If the Supreme Court sides with Bayer on preemption, it could severely limit new claims. If it sides with plaintiffs, expect another surge of filings in 2026.
Roundup Lawsuit Settlement Amounts 2026
Settlement amounts in Roundup cases vary widely based on cancer severity, exposure history, and individual case strength. In 2026, typical settlement ranges are expected to mirror the tiers established in prior rounds.
Most individual settlements have fallen between $5,000 and $250,000. Stronger cases with clear cancer diagnoses and well-documented Roundup use have settled for $100,000 to $2 million or more.
The highest jury verdicts paint a different picture. These are the amounts juries awarded before reductions on appeal.
| Case | Original Verdict | Reduced Amount |
|---|---|---|
| Johnson v. Monsanto (2018) | $289 million | $78.5 million |
| Hardeman v. Monsanto (2019) | $80 million | $25.3 million |
| Pilliod v. Monsanto (2019) | $2.055 billion | $86.7 million |
Settlements and verdicts are two different things. A settlement is a negotiated agreement. A verdict is a jury’s decision. Most cases settle before going to trial.
For 2026 claimants, the amount depends on several factors. Your cancer type, stage at diagnosis, age, and how long you used Roundup all play a role. The strongest payouts go to people with confirmed non-Hodgkin lymphoma and years of documented exposure.
Cases involving death or terminal diagnoses tend to settle at the higher end. Claims with less severe conditions or limited proof of Roundup use settle for less.
Key Takeaway: The Roundup MDL is still active in 2026, with individual settlements typically ranging from $5,000 to over $2 million depending on cancer severity and exposure history.
Roundup Cancer Lawsuit Payout Per Person
The average Roundup cancer lawsuit payout per person from the settlement fund has been approximately $120,000 to $180,000. That said, “average” can be misleading because payouts vary enormously.
Some claimants received as little as $5,000. Others received well over $1 million. The payout structure uses a tiered points system that scores each claim.
Here’s a simplified breakdown of how the tiers generally work:
| Tier | Cancer Severity | Exposure Level | Estimated Payout Range |
|---|---|---|---|
| Tier 1 (Highest) | Aggressive NHL, terminal | 10+ years heavy use | $500,000 to $2 million+ |
| Tier 2 | Confirmed NHL, in remission | 5 to 10 years regular use | $150,000 to $500,000 |
| Tier 3 | Early-stage NHL or B-cell lymphoma | 2 to 5 years occasional use | $25,000 to $150,000 |
| Tier 4 (Lowest) | Other lymphomas, weaker link | Minimal or undocumented use | $5,000 to $25,000 |
Your payout depends on your individual score. The scoring formula weighs your diagnosis, medical records, usage history, age, and whether Roundup was your primary herbicide exposure.
People who can provide receipts, purchase records, or employer documentation of Roundup use tend to score higher. Medical records linking the cancer diagnosis to glyphosate exposure carry the most weight.
Family members of deceased Roundup users can file wrongful death claims. Those cases often settle near the top of the range because the harm is irreversible.
Who Qualifies for Roundup Lawsuit
You may qualify for a Roundup lawsuit if you used Roundup products and were later diagnosed with cancer, particularly non-Hodgkin lymphoma or a related blood cancer.
The basic qualification checklist includes three things:
- Roundup exposure: You personally used or were regularly exposed to Roundup herbicide products
- Cancer diagnosis: You developed non-Hodgkin lymphoma, chronic lymphocytic leukemia, B-cell lymphoma, or another linked cancer
- Timing: Your cancer diagnosis came after a period of Roundup use or exposure
Both professional and residential users qualify. Farmers, landscapers, groundskeepers, nursery workers, and agricultural laborers have filed claims. Homeowners who used Roundup in their yards for years have also qualified.
You don’t need to prove you used Roundup every single day. Consistent use over a period of two or more years is generally sufficient. Even seasonal use over multiple years has qualified some claimants.
Family members of deceased users may file on behalf of the estate. Spouses, children, or appointed representatives can bring wrongful death or survival claims.
One thing that does not automatically qualify you: simply buying Roundup. You need a cancer diagnosis connected to your exposure. Owning the product alone is not enough.
Roundup Lawsuit Eligibility Requirements
Roundup lawsuit eligibility requires meeting specific medical, exposure, and legal criteria that go beyond just having used the product. The requirements are more detailed than most people expect.
Here are the core eligibility factors:
| Requirement | Details |
|---|---|
| Cancer Diagnosis | Non-Hodgkin lymphoma (most common), chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, or other linked cancers |
| Exposure Duration | Minimum 2+ years of regular use is typical; longer exposure strengthens the claim |
| Exposure Type | Direct application (spraying), occupational contact, or significant residential proximity |
| Statute of Limitations | Varies by state; typically 2 to 3 years from diagnosis or discovery of the link |
| Documentation | Medical records confirming diagnosis; any evidence of Roundup purchase or use |
Your state’s statute of limitations is a critical factor. Each state sets its own deadline for filing personal injury claims. In many states, you have 2 to 3 years from the date you were diagnosed or from the date you learned Roundup may have caused your cancer.
Some states use a “discovery rule.” This means the clock doesn’t start until you reasonably should have known about the connection. That rule has allowed some people diagnosed years ago to still file claims.
You do not need to have used a specific Roundup formula. All glyphosate-based Roundup products are included in the litigation. Roundup Original, Roundup Ready-To-Use, Roundup Concentrate, and Ranger Pro are all covered.
Key Takeaway: You need a qualifying cancer diagnosis, documented Roundup exposure of at least two years, and your claim must fall within your state’s statute of limitations to be eligible.
Roundup Lymphoma Lawsuit
The Roundup lymphoma lawsuit specifically targets the connection between glyphosate exposure and non-Hodgkin lymphoma (NHL). This is the cancer type at the center of nearly every Roundup claim.
In 2015, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as “probably carcinogenic to humans.” That classification focused heavily on the link to NHL.
Non-Hodgkin lymphoma is a cancer of the lymphatic system. It affects white blood cells and can appear in lymph nodes, the spleen, bone marrow, or other organs. Subtypes linked to Roundup include:
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Marginal zone lymphoma
- Mantle cell lymphoma
- Chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL)
- Burkitt lymphoma
DLBCL is the most common subtype in Roundup cases. It’s also one of the more aggressive forms, which tends to result in higher settlement values.
Multiple peer-reviewed studies have found a statistical association between glyphosate use and NHL risk. A 2019 meta-analysis published in Mutation Research found a 41% increased risk of NHL among people with the highest levels of glyphosate exposure.
Bayer and Monsanto have consistently argued that glyphosate is safe. They point to EPA assessments that found the chemical “not likely to be carcinogenic.” But juries have repeatedly sided with plaintiffs, finding that Monsanto failed to warn users about the cancer risk.
Roundup Weed Killer Cancer Claims
Roundup weed killer cancer claims are the individual lawsuits filed by people who believe Roundup caused their cancer diagnosis. Over 100,000 such claims have been filed nationwide.
These claims aren’t limited to one type of cancer, though NHL dominates. Other cancers that have appeared in Roundup litigation include:
- Hairy cell leukemia
- T-cell lymphoma
- Multiple myeloma
- Brain cancer (some claims, less established link)
The strongest claims share common characteristics. Long-term use, professional-level exposure, a clear NHL diagnosis, and solid medical documentation all strengthen a case.
Weak claims typically involve short exposure periods, cancers with a less established glyphosate link, or missing medical records. These claims may still settle, but at much lower amounts.
One important factor is the “latency period.” Cancer doesn’t appear overnight. The time between Roundup exposure and cancer diagnosis can span 5 to 20 years or more. This means someone who stopped using Roundup in 2010 and was diagnosed in 2024 can still file a valid claim.
Agricultural workers represent the largest group of claimants. But residential users make up a significant portion too. Homeowners who sprayed Roundup on driveways, garden beds, or fence lines for years have successfully filed claims and received settlements.
How to File a Roundup Lawsuit Claim
Filing a Roundup lawsuit claim in 2026 involves gathering your documentation, connecting with a qualified attorney, and submitting your case for evaluation. The process is more straightforward than most people think.
Here’s the step-by-step process:
Step 1: Gather your records. Collect your medical records showing your cancer diagnosis. Pull together any evidence of Roundup use: purchase receipts, photos, employment records, or even personal calendars noting application dates.
Step 2: Contact a mass tort attorney. Roundup cases require attorneys experienced in product liability and mass tort litigation. Most firms handle these cases on a contingency fee basis, meaning you pay nothing upfront. The attorney only gets paid if you win or settle.
Step 3: Case evaluation. Your attorney reviews your medical history, exposure timeline, and documentation strength. They’ll assess where your case falls in the settlement tier structure.
Step 4: Filing. Your attorney files the lawsuit in the appropriate jurisdiction, either in the MDL or in a state court depending on your circumstances.
Step 5: Settlement negotiation or trial. Most cases settle without going to trial. Your attorney negotiates with Bayer’s legal team. If they can’t reach an agreement, the case proceeds to trial.
| Filing Step | What You Need |
|---|---|
| Medical Records | Cancer diagnosis documentation, treatment history |
| Exposure Proof | Receipts, work records, photos, witness statements |
| Attorney | Mass tort or product liability firm, contingency basis |
| Timeline | File before your state’s statute of limitations expires |
The contingency fee structure is standard in Roundup cases. Typical attorney fees range from 33% to 40% of the settlement amount. This means no out-of-pocket legal costs for claimants.
Key Takeaway: Filing a Roundup claim requires medical records showing a cancer diagnosis, evidence of Roundup use, and a mass tort attorney who works on contingency with no upfront cost.
Roundup Lawsuit Deadline 2026
The Roundup lawsuit deadline depends on your state’s statute of limitations for personal injury claims, and these vary significantly from state to state. There is no single national deadline.
Most states set the filing window at 2 to 3 years from either the date of diagnosis or the date you discovered (or should have discovered) the link between Roundup and your cancer.
Here are examples of statute of limitations by state:
| State | Statute of Limitations | Starting Point |
|---|---|---|
| California | 2 years | Date of injury or discovery |
| Texas | 2 years | Date of injury or discovery |
| Florida | 4 years | Date of injury or discovery |
| New York | 3 years | Date of injury |
| Illinois | 2 years | Date of injury or discovery |
| Pennsylvania | 2 years | Date of injury or discovery |
| Ohio | 2 years | Date of injury or discovery |
The “discovery rule” is critical here. If you were diagnosed with NHL in 2020 but didn’t learn about the Roundup connection until 2024, your clock may have started in 2024. This varies by jurisdiction.
For 2026, the key concern is that people diagnosed several years ago may be approaching or passing their deadline. If you’ve been sitting on a potential claim, the time to act is now.
Some states also have special rules for minors, deceased claimants, and cases involving government employers. These can extend or modify the standard deadline.
Don’t assume you’ve missed your window without checking. Your attorney can evaluate your specific situation and determine whether your claim is still timely.
Is the Roundup Lawsuit Still Open 2026
Yes, the Roundup lawsuit is still open in 2026, and new claims are still being accepted. The litigation has not been closed or finalized.
While Bayer has settled the majority of the original claims from the 2020 settlement round, new cases continue to be filed. The MDL remains active, and state courts continue to accept Roundup cancer cases.
Several factors keep the litigation alive:
- New cancer diagnoses linked to past Roundup use continue to emerge
- The latency period for NHL means people exposed years ago are only now being diagnosed
- Bayer’s settlement fund did not resolve all existing claims
- The Supreme Court preemption case could open or close the door to future claims
Bayer has publicly stated its goal to resolve the Roundup litigation. But with tens of thousands of claims still pending, that resolution is not yet complete.
If you’re wondering whether you’re “too late,” the answer for most people in 2026 is no. As long as your state’s statute of limitations hasn’t expired, you can still file a claim.
The only scenario where the litigation could effectively close is if the Supreme Court rules in Bayer’s favor on federal preemption. That ruling could prevent future failure-to-warn claims. But even then, pending cases would likely continue through the system.
Monsanto Roundup Lawsuit Settlement
The Monsanto Roundup lawsuit settlement is the landmark $10.9 billion agreement Bayer announced in June 2020 to resolve approximately 75% of the Roundup cancer claims pending at that time. It remains one of the largest product liability settlements in U.S. history.
Bayer acquired Monsanto in 2018 for $63 billion, inheriting the Roundup litigation along with the company. Monsanto had manufactured and marketed Roundup since 1974.
Here’s how the settlement breaks down:
| Component | Amount |
|---|---|
| Settlement of existing claims | $8.8 to $9.6 billion |
| Future claims reserve | $1.25 billion (initial proposal, later modified) |
| Total commitment | $10.9 billion |
The settlement did not include an admission of guilt. Bayer has consistently maintained that Roundup is safe and does not cause cancer. The settlement was framed as a business decision to reduce litigation uncertainty.
Not all claimants accepted the settlement terms. Some chose to pursue their cases individually, hoping for larger payouts through trials or separate negotiations.
The settlement was not a single class action payout. Each claim was evaluated individually. Claimants received different amounts based on the strength of their case, their cancer diagnosis, and their exposure history.
Monsanto’s internal documents, revealed during trial discovery, played a major role in the litigation. Emails and memos showed the company worked to influence scientific research and ghostwrote studies defending glyphosate’s safety. Those documents damaged Monsanto’s credibility with juries.
Key Takeaway: Bayer’s $10.9 billion settlement covered most existing claims, but it did not end the litigation, and new Roundup cases are still being filed and settled individually in 2026.
Roundup Class Action Lawsuit Payout Amounts
Roundup class action lawsuit payout amounts have ranged from a few thousand dollars to tens of millions, depending on whether the case settled or went to trial. The spread is enormous.
For settled claims through the Bayer settlement fund, here’s the general range:
| Claim Strength | Payout Range |
|---|---|
| Strong (terminal NHL, long exposure, strong documentation) | $500,000 to $2 million+ |
| Moderate (confirmed NHL, solid exposure, good records) | $100,000 to $500,000 |
| Average (NHL diagnosis, moderate exposure) | $25,000 to $100,000 |
| Weak (limited exposure, less direct cancer link) | $5,000 to $25,000 |
Trial verdicts have produced much higher numbers, but they are the exception. Only a handful of cases have gone to trial. The three bellwether verdicts (Johnson, Hardeman, Pilliod) produced headline-grabbing numbers that were later reduced on appeal.
After attorney fees (typically 33% to 40%) and case costs, the net amount claimants take home is lower than the gross settlement figure. A $150,000 settlement might net roughly $90,000 to $100,000 after legal fees.
Medical liens can further reduce the take-home amount. If your health insurance or Medicare/Medicaid paid for cancer treatment, they may have a right to reimbursement from your settlement proceeds.
Despite these deductions, Roundup payouts remain significant. For many claimants, the settlement provides critical financial relief after years of cancer treatment, lost wages, and emotional suffering.
Roundup Settlement Payout Timeline
The Roundup settlement payout timeline from claim filing to receiving money typically takes 12 to 24 months for settled cases. Some cases resolve faster; others take years.
Here’s a general timeline of how the process unfolds:
| Phase | Estimated Duration |
|---|---|
| Initial case evaluation | 2 to 4 weeks |
| Filing and documentation | 1 to 3 months |
| Settlement negotiation | 6 to 18 months |
| Settlement approval and processing | 2 to 6 months |
| Payout delivery | 30 to 90 days after approval |
| Total estimated time | 12 to 24 months |
Cases that go to trial take much longer. A trial can add 2 to 5 years to the process, including appeals. That’s why most claimants and attorneys prefer to settle.
Some claimants who joined the original 2020 settlement are still waiting for full payment. The sheer volume of claims has created processing delays. With over 100,000 cases, the administrative machinery moves slowly.
For people filing new claims in 2026, the timeline depends on where the broader litigation stands. If the Supreme Court rules against Bayer on preemption, settlement negotiations may accelerate. If Bayer wins, the company may become less willing to offer generous settlements.
Think of it like waiting in a long line at the DMV. The process works, but patience is required. Your attorney should provide regular updates on your claim’s status.
Bayer Roundup Settlement Update
Bayer’s Roundup settlement strategy continues to evolve in 2026 as the company balances ongoing litigation costs against its desire to move past the Roundup controversy. The company has spent over $16 billion total on Roundup-related litigation and settlements.
Key developments heading into 2026:
- Bayer increased its litigation reserves to approximately $16 billion total through 2025
- The company has resolved roughly 100,000 claims since 2020
- An estimated 30,000 to 40,000 claims remain pending or newly filed
- Bayer announced it would remove glyphosate from residential Roundup products in the U.S. starting in 2023 (replacing it with other active ingredients)
- The Supreme Court preemption case remains the most critical pending development
Bayer’s decision to reformulate residential Roundup products is significant. While the company insists the change is about litigation risk rather than safety concerns, it effectively acknowledges the legal liability created by glyphosate.
The company’s stock price has been significantly affected by Roundup litigation. Investors have pressured Bayer management to resolve the cases and provide certainty about future liabilities.
For claimants in 2026, Bayer’s financial position matters. The company remains profitable and capable of paying settlements. There is no risk of Bayer going bankrupt or being unable to fund payouts. The company reported $47.6 billion in revenue in 2024.
Key Takeaway: Bayer has spent over $16 billion on Roundup litigation and settlements, remains financially capable of funding ongoing payouts, and the Supreme Court preemption decision will shape the 2026 settlement outlook.
Roundup Lawsuit Tax Implications
Roundup lawsuit settlement money is generally taxable in some ways and tax-free in others, depending on what the payment compensates. Understanding the tax treatment can save you thousands of dollars.
The IRS follows specific rules for lawsuit settlements under Section 104 of the Internal Revenue Code. Here’s the breakdown:
| Settlement Component | Taxable? |
|---|---|
| Compensation for physical injuries/illness | No (tax-free) |
| Medical expense reimbursement (not previously deducted) | No (tax-free) |
| Medical expense reimbursement (previously deducted) | Yes |
| Lost wages | Yes (income tax + payroll tax) |
| Emotional distress (related to physical injury) | No (tax-free) |
| Emotional distress (not related to physical injury) | Yes |
| Punitive damages | Yes (always taxable) |
| Interest on settlement | Yes |
| Attorney fees | Depends on allocation |
The good news for most Roundup claimants: because these settlements compensate for physical illness (cancer), the bulk of the payment is typically tax-free.
However, if any portion of your settlement is designated as lost wages, that amount will be subject to income tax. Punitive damages, if included, are always taxable.
Attorney fees add a complication. In some cases, you may owe taxes on the gross settlement amount even though your attorney took 33% to 40% off the top. Tax law on this point varies depending on the fee structure and your state.
You should work with a tax professional who has experience with lawsuit settlements. Proper allocation of your settlement across different categories can minimize your tax bill significantly.
Roundup Settlement Funding Options
Roundup settlement funding, also called pre-settlement funding or lawsuit loans, provides cash advances to claimants who need money before their case resolves. These advances are available to people with pending Roundup claims.
Waiting 12 to 24 months (or longer) for a settlement payout creates financial hardship for many cancer patients. Medical bills pile up. Lost income strains household budgets. Pre-settlement funding addresses that gap.
Here’s how it works:
- A funding company reviews your pending Roundup claim
- They assess the likely settlement value
- They advance you a portion of your expected payout (typically 10% to 20%)
- You repay the advance plus fees from your settlement proceeds
- If you don’t win or settle, you typically owe nothing
| Funding Detail | Typical Terms |
|---|---|
| Advance Amount | $5,000 to $100,000 |
| Fee Structure | Monthly or annual percentage |
| Annual Cost | 15% to 60% (varies widely) |
| Repayment | Deducted from settlement only |
| Risk if You Lose | No repayment required (non-recourse) |
The fees on pre-settlement funding are high. Think of it like a payday loan for lawsuits. A $20,000 advance could cost you $30,000 to $40,000 or more by the time your case settles, depending on how long it takes.
Some states regulate pre-settlement funding companies and cap their fees. Others have minimal oversight. Read the contract carefully before signing anything.
Your attorney should review any funding agreement before you commit. Many attorneys discourage pre-settlement funding because of the high costs, but they recognize that some clients have no other options.
Key Takeaway: Most Roundup settlement money for physical illness is tax-free under IRS rules, and pre-settlement funding is available for claimants who need cash before their case resolves, though it comes with high fees.
Frequently Asked Questions
How much money can I get from a Roundup lawsuit in 2026?
Settlement amounts range from $5,000 to over $2 million depending on your cancer diagnosis, exposure history, and case strength.
Most settled claims fall between $25,000 and $250,000.
Trial verdicts have produced much higher awards, but most cases settle without a trial.
Is it too late to file a Roundup class action lawsuit?
No, the Roundup litigation is still open in 2026, and new claims are being accepted.
Your eligibility depends on your state’s statute of limitations, typically 2 to 3 years from diagnosis or discovery.
Contact a mass tort attorney to determine if your claim is still within the filing window.
What type of cancer qualifies for a Roundup settlement?
Non-Hodgkin lymphoma (NHL) is the primary qualifying cancer, including subtypes like DLBCL, follicular lymphoma, and mantle cell lymphoma.
Chronic lymphocytic leukemia and other B-cell lymphomas have also qualified.
Other cancers may be accepted on a case-by-case basis, though the connection to glyphosate is less established.
How long does a Roundup lawsuit take to settle?
Most Roundup cases take 12 to 24 months from filing to payout.
Cases that go to trial can take 2 to 5 years or longer, including appeals.
The overall timeline depends on case complexity, documentation strength, and court scheduling.
Do I have to pay taxes on my Roundup settlement money?
The portion compensating physical illness (cancer) is generally tax-free under IRS Section 104.
Any amounts allocated to lost wages, punitive damages, or interest are taxable.
Work with a tax professional experienced in lawsuit settlements to minimize your tax burden.
The Roundup litigation continues to affect thousands of families across the country in 2026. Whether you’re just learning about your rights or you’ve been waiting on a pending claim, the most important step is understanding where you stand.
Check your state’s filing deadline. Gather your medical records and Roundup usage history. Connect with a qualified mass tort attorney who can evaluate your case at no upfront cost.
Don’t wait until your deadline passes. The clock is ticking on every Roundup claim, and acting now protects your right to compensation.
